Aims and structure of the German Research Consortium BipoLife for the study of bipolar disorder
Authors:
- Philipp S. RitterPRPhilipp S. Ritter
- Felix BermpohlFBFelix Bermpohl
- Oliver GruberOGOliver Gruber
- Martin HautzingerMHMartin Hautzinger
- Andreas JansenAJAndreas Jansen
- Georg JuckelGJGeorg Juckel
- Tilo KircherTKTilo Kircher
- Martin LambertMLMartin Lambert
- Christoph MulertCMChristoph Mulert
- Andrea PfennigAPAndrea Pfennig
- Andreas ReifARAndreas Reif
- Otto RienhoffOROtto Rienhoff
Open Access
- 21 November 2016
- journal article
- review article
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 4 (1) , 1-9
Abstract
Bipolar disorder is a severe and heterogeneous mental disorder. Despite great advances in neuroscience over the past decades, the precise causative mechanisms at the transmitter, cellular or network level have so far not been unraveled. As a result, individual treatment decisions cannot be tailor-made and the uncertain prognosis is based on clinical characteristics alone. Although a subpopulation of patients have an excellent response to pharmacological monotherapy, other subpopulations have been less well served by the medical system and therefore require more focused attention. In particular individuals at high risk of bipolar disorder, young patients in the early stages of bipolar disorder, patients with an unstable highly relapsing course and patients with acute suicidal ideation have been identified as those in need. A research consortium of ten universities across Germany has therefore implemented a 4 year research agenda including three randomized controlled trials, one epidemiological trial and one cross-sectional trial to address these areas of unmet needs. The topics under investigation will be the improvement of early recognition, specific psychotherapy, and smartphones as an aid for early episode detection and biomarkers of lithium response. A subset of patients will be investigated utilizing neuroimaging (fMRI), neurophysiology (EEG), and biomaterials (genomics, transcriptomics). This article aims to outline the rationale, design, and methods of these individual studies.Keywords
Funding Information
- German Ministry of Research and Education (Bundesministerium für Bildung und Forschung; www.bmbf.de) (01EE1404A-H)
This publication has 51 references indexed in Scilit:
- MRI Phantoms – Are There Alternatives to Agar?PLOS ONE, 2013
- Interactive Multimodal Ambulatory Monitoring to Investigate the Association between Physical Activity and AffectFrontiers in Psychology, 2013
- Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trialBipolar Disorders, 2011
- Clinical course of children with a depressive spectrum disorder and transient manic symptomsBipolar Disorders, 2010
- The impact of staging bipolar disorder on treatment outcome of family psychoeducationJournal of Affective Disorders, 2010
- Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind taskMolecular Psychiatry, 2010
- When Desire Collides with Reason: Functional Interactions between Anteroventral Prefrontal Cortex and Nucleus Accumbens Underlie the Human Ability to Resist Impulsive DesiresJournal of Neuroscience, 2010
- Interventions for helping people recognise early signs of recurrence in bipolar disorderCochrane Database of Systematic Reviews, 2007
- Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorderClinical Practice & Epidemiology in Mental Health, 2007
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978